Elitek (rasburicase)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) June 2016 BOX WARNING Change 1st section of Anaphylaxis to read: Hypersensitivity Reactions: Elitek can cause serious and fatal...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts